Locoregional Spread and Survival of Stage IIA1 versus Stage IIA2 Cervical Cancer |
Hongladaromp, Waroonsiri
(Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University)
Tantipalakorn, Charuwan (Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University) Charoenkwan, Kittipat (Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University) Srisomboon, Jatupol (Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University) |
1 | Soisson AP, Soper JT, Clarke-Pearson DL, et al (1990). Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol, 37, 390-5. DOI ScienceOn |
2 | Steed H, Capstick V, Schepansky A, et al (2006). Early cervical cancer and parametrial involvement: is it significant? Gynecol Oncol, 103, 53-7. DOI ScienceOn |
3 | Sutton GP, Bundy BN, Delgado G, et al (1992). Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Am J Obstet Gynecol, 166, 50-3. DOI ScienceOn |
4 | Trattner M, Graf AH, Lax S, et al (2001). Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol Oncol, 82, 11-6. DOI ScienceOn |
5 | Verleye L, Vergote I, Reed N, et al (2009). Quality assurance for radical hysterectomy for cervical cancer: the view of the European Organization for Research and Treatment of Cancer--Gynecological Cancer Group (EORTC-GCG). Ann Oncol, 20, 1631-8. DOI ScienceOn |
6 | Pecorelli S, Zigliani L, Odicino F (2009). Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet, 105, 107-8. DOI ScienceOn |
7 | Mabuchi S, Okazawa M, Matsuo K, et al (2012). Impact of histological subtype on survival of patients with surgicallytreated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma. Gynecol Oncol, 127, 114-20. DOI ScienceOn |
8 | Macdonald OK, Chen J, Dodson M, et al (2009). Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix. Am J Clin Oncol, 32, 411-6. DOI ScienceOn |
9 | Ngamcherttakul V, Ruengkhachorn I (2012). Ovarian metastasis and other ovarian neoplasms in women with cervical cancer stage IA-IIA. Asian Pac J Cancer Prev, 13, 4525-9. DOI ScienceOn |
10 | Perez CA, Grigsby PW, Chao KS, et al (1998). Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys, 41, 307-7. DOI ScienceOn |
11 | Peters WA, III, Liu PY, Barrett RJ, et al (2000). Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol, 18, 1606-13. |
12 | Quinn MA, Benedet JL, Odicino F, et al (2006). Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet, 95, 43-103. DOI ScienceOn |
13 | Sakuragi N (2007). Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer. Int J Clin Oncol, 12, 165-75. DOI |
14 | Shimada M, Kigawa J, Nishimura R, et al (2006). Ovarian metastasis in carcinoma of the uterine cervix. Gynecol Oncol, 101, 234-7. DOI ScienceOn |
15 | Hopkins MP, Morley GW (1991). Radical hysterectomy versus radiation therapy for stage IB squamous cell cancer of the cervix. Cancer, 68, 272-7. DOI |
16 | Horn LC, Fischer U, Raptis G, et al (2007). Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol, 107, 310-5. DOI ScienceOn |
17 | Garg G, Shah JP, Toy EP, et al (2011). Stage IIA1 versus stage IIA2 cervical cancer: does the new staging criteria predict survival? Int J Gynecol Cancer, 21, 711-6. DOI ScienceOn |
18 | Ho CM, Chien TY, Huang SH, et al (2004). Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol Oncol, 93, 458-64. DOI ScienceOn |
19 | Hosaka M, Watari H, Mitamura T, et al (2011). Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy. Int J Clin Oncol, 16, 33-8. DOI |
20 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
21 | Lai CH, Hsueh S, Hong JH, et al (1999). Are adenocarcinomas and adenosquamous carcinomas different from squamous carcinomas in stage IB and II cervical cancer patients undergoing primary radical surgery? Int J Gynecol Cancer, 9, 28-36. DOI ScienceOn |
22 | Lai JC, Chou YJ, Huang N, et al (2013). Survival analysis of Stage IIA1 and IIA2 cervical cancer patients. Taiwan J Obstet Gynecol, 52, 33-8. DOI ScienceOn |
23 | Landoni F, Maneo A, Colombo A, et al (1997). Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet, 350, 535-40. DOI ScienceOn |
24 | Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-7. DOI ScienceOn |
25 | Landoni F, Zanagnolo V, Lovato-Diaz L, et al (2007). Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study). Int J Gynecol Cancer, 17, 623-8. DOI ScienceOn |
26 | Covens A, Rosen B, Murphy J, et al (2002). How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol, 84, 145-9. DOI ScienceOn |
27 | Delgado G, Bundy B, Zaino R, et al (1990). Prospective surgicalpathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol, 38, 352-7. DOI ScienceOn |
28 | Frumovitz M, Sun CC, Schmeler KM, et al (2009). Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol, 114, 93-9. DOI ScienceOn |
29 | Takeda N, Sakuragi N, Takeda M, et al (2002). Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand, 81, 1144-51. DOI ScienceOn |